Dialysis Access Treatment Devices – Market Insights – United States

The US dialysis access treatment device market will be driven by the increasing patient population in need of dialysis care, the launch of new devices featuring innovative technologies, and favorable clinical trial outcomes demonstrating the clinical advantages of dialysis access treatment devices. However, the market is expected to face some headwinds from increasing pressure related to the implementation of a nationwide dialysis care system.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for dialysis access treatment devices in the US from 2019 through 2032.

The anticipated launch of devices featuring incremental safety and effectiveness enhancements will impact the dialysis access treatment device market.

What are the procedure groups that will be most impacted by the introduction of new devices?

How will surgical AVF procedures and use of AVGs and dialysis catheters be affected by the entry of percutaneous AVF catheters?

What other emerging technologies are on the horizon that can bring competition to the dialysis access creation market?

Certain segments within the dialysis access creation and maintenance spaces will fuel the growth of their respective markets in the coming years.

What are the product types and their subtypes that will exhibit relatively high growth rates over the forecast period?

What impact will recent clinical trial results for percutaneous AVF have on the dialysis access creation market?

What is the competitive outlook in the percutaneous thrombectomy segment, considering the current competitive landscape and the launch of a new device?

Policy decisions and guidelines dictating reimbursement rates and affecting site of service will have a large influence on the dialysis access treatment device market.

What has been the impact of recent dialysis patient management guidelines on choice of site of service for dialysis maintenance procedures?

How have recent reimbursement policies affected dialysis access maintenance site-of-service trends?

How can manufacturers adapt to these reimbursement changes to succeed in the dialysis access maintenance device market?

The COVID-19 pandemic contributed to an overall increase in the total volume of dialysis access treatment procedures.

What are the key factors that led to increased uptake of dialysis access treatment procedures during the course of COVID-19?

How did the impact of COVID-19 and the change in device usage in subsequent years vary in different dialysis access treatment device segments?

Table of contents

Dialysis Access Treatment Devices - Market Insights - United States

Lewis Joo

Lewis Joo is a senior analyst on the Cardiovascular Medtech Insights team at Clarivate. Lewis holds a Master’s degree in Medical Biophysics from the University of Toronto. Prior to his current position, Lewis worked at the Sunnybrook Health Sciences Center, working on preclinical imaging research projects on neurodegeneration.

Contact sales Login to access report

Back to all Medtech Insights reports